Delivery Order SPE2DR25D3103-SPE2DR26F9K75
- Not listed
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Lenvima 18 mg daily dose in a 90-day supply quantity. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Lenvima 10 mg daily dose (30-count) with a ceiling value of $10,773.72. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The order is scheduled for completion by December 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count quantity, with a ceiling value of $10,223.24 and a firm fixed price structure. The contract carries an ultimate completion date of November 18, 2025, and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose, 60-count units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 5, 2025. The award was issued on July 15, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for the supply of LENVIMA 18 mg daily dose in a 90-day supply. The contract, executed on April 24, 2025, with completion targeted for May 15, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $18,559.58. The contract is for the supply of the pharmaceutical product Lenvima 14 mg daily dose, with a completion date of June 5, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently...
- The Defense Logistics Agency awarded a $10,773.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of LENVIMA 8 mg daily dose tablets in quantities of 60 units. The contract is scheduled for completion by December 31, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Lenvima 14 mg daily dose 60s. The contract has a ceiling value of $18,559.58 and a period of performance through April 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a task order under a larger indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp for the supply of Lenvima (8 mg daily dose, 60-count), a pharmaceutical product used in cancer treatment. This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,910.95 firm fixed-price delivery order is for the supply of the medication Lenvima 14 mg, with a performance period extending to May 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9K75Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lenvima 8 mg daily dose in quantities of 60 units, with a ceiling value of $10,773.72 and completion targeted for December 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement. The award is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, maintains a substantial portfolio of federal contracts supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Lenvima delivery, a oncology medication, exemplifies the company's capability to fulfill federal medical supply needs across diverse pharmaceutical categories while operating through the DLA's Medical Supply Chain network to support military and veteran healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 11/30/25 |